Institute for Neuro Immune Medicine

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

The Institute for Neuro-Immune Medicine (INIM), at Nova Southeastern University in Fort Lauderdale, Florida, United States, is led by Nancy Klimas, MD.

Notable people[edit | edit source]

  • Nancy Klimas, Director of INIM and Chair of Clinical Immunology at Nova Southeastern University[1]
  • Amanpreet Cheema PhD, Director, Division of Clinical Research [1]
  • Irma Rey, MD
  • Irina Rozenfeld, DNP, ARNP
  • Annette Fornos, MD
  • Violetta Rozenfeld, DNP, ARNP
  • Mary Ann Fletcher (retired), Schemel Professor for Neuro Immune Medicine[2]
  • Fanny Collado, Research Nurse Coordinator and Health Science Specialist[3]

Notable studies[edit | edit source]

  • 2018, Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns[4]

Current research[edit | edit source]

Crowd-sourced ME/CFS Gene Study[edit | edit source]

Beginning in 2015, Dr. Klimas has asked patients to provide their genetic data (either via or 23andMe) to develop a large-scale study to look for patterns and subgroups in the genetics of ME/CFS patients.[5]

ME/CFS Detecting Mycotoxin Subgroup[edit | edit source]

This is a pilot study to look at mycotoxins (toxic metabolites produced by molds/fungi) in patients with ME/CFS. It aims to:

  • find out whether the Environmental Exposure Questionnaire (EEQ) can be used to assess for mycotoxin exposure in ME/CFS patients
  • assess if the mycotoxin exposure results in more severe symptoms in ME/CFS patients
  • future studies will use the blood samples collected to discover if there is a "specific immune or metabolic dysfunction, or epigenetic changes" related to mycotoxin exposure in ME/CFS patients[6]

Clinical Nutrition Profile for ME/CFS[edit | edit source]

The Clinical Nutrition Profile (CNP) project aims to create a profile of people with ME/CFS based on nutritional biomarkers, their dietary intake and other clinically relevant data. By investigating nutritional patterns and deficiencies associated with the ME/CFS it could help "identifying disease targets, improving overall organ system function, allowing body to heal and potentially resetting homeostatic function" to improve patient response to current treatments.[7]

Funding[edit | edit source]

Online presence[edit | edit source]

See also[edit | edit source]

References[edit | edit source]